[1] van Ruth S, Acherman Y I,Van de Vijver M J, et al. Pseudomyxoma peritonei:a review of 62 cases[J]. Eur J Surg Oncol, 2003, 29(8):682-688.
[2] Costa M J. Pseudomyxoma peritonei. Histologic predictors of patient survival[J]. Arch Pathol Lab Med, 1994, 118(12):1215-1219.
[3] Seidman J D, Elsayed A M, Sobin L H, et al. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases[J]. Am J Surg Pathol, 1993, 17(1):22-34.
[4] Ronnett B M, Kurman R J, Zahn C M, et al. Pseudomyxoma peritonei in women:A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential[J]. Hum Pathol, 1995, 26(5):509-524.
[5] Sugarbaker P H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?[J]. Lancet Oncol, 2006, 7(1):69-76.
[6] Shetty S, Natarajan B, Thomas P, et al. Proposed classification of pseudomyxoma peritonei:influence of signet ring cells on survival[J]. Am Surg, 2013, 79(11):1171-1176.
[7] Davison J M, Choudry H A, Pingpank J F, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms:identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade[J]. Mod Pathol, 2014, 27(11):1521-1539.
[8] Järvinen P, Järvinen H J, Lepistö A. Survival of patients with pseudomyxoma peritonei treated by serial debulking[J]. Colorectal Dis, 2010, 12(9):868-872.
[9] Wagner P L, Austin F, Zenati M, et al. Oncologic risk stratification following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal carcinomatosis[J]. Ann Surg Oncol, 2016, 23(5):1587-1593.
[10] Ikejiri K, Anai H, Kitamura K, et al. Pseudomyxoma peritonei concomitant with early gastric cancer:report of a case[J]. Surg Today, 1996, 26(11):923-925.
[11] De Bree E, Witkamp A, Van Vijver M, et al. Unusual origins of Pseudomyxoma peritonei[J]. Surg Oncol, 2015, 75(4):270-274.
[12] Chejfec G, Rieker W J, Jablokow V R, et al. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas[J]. Gastroenterology, 1986, 90(1):202-205.
[13] Liu Y, Ishibashi H, Hirano M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei arising from urachus[J]. Ann Sur Oncol, 2015, 22(8):2799-2805.
[14] Ronnett B M, Seidman J D. Mucinous tumors arising in ovarian mature cystic teratomas:relationship to the clinical syndrome of pseudomyxoma peritonei[J]. Am J Surg Pathol, 2003, 27(5):650-657.
[15] Carr N J, Finch J, Ilesley I C, et al. Pathology and prognosis in pseudomyxoma peritonei:a review of 274 cases[J]. J Clin Pathol, 2012, 65(10):919-923.
[16] 唐平,肖立,王巍,等.胰腺囊性肿瘤的多层螺旋CT表现与病理对照[J].中国临床医学影像杂志,2008,19(9):638-641.
[17] Imaoka H, Yamao K, Hijioka S, et al. Pseudomyxoma peritonei arising from intraductal papillary neoplasm after surgical pancreatectomy:report of 2 cases and review of the literature[J]. Clin J Gastroenterol, 2012, 5(1):15-19.
[18] Oh H C, Seo D W, Song T J, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts[J]. Gastroenterology, 2011, 140(1):172-179.
[19] Baratti D, Kusamura S, Milione M, et al. Pseudomyxoma peritonei of extra-appendiceal origin:A Comparative study[J]. Ann Surg Oncol, 2016, 23(13):4222-4230. |
